Aug 13, 2025 5:00pm EDT Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results
Jul 8, 2025 8:00am EDT Dermata Receives Notice of Grant of Australian Patent for Topical Botulinum Toxin Treatment for Hyperhidrosis
